Abstract
Safe and efficient gene transfer systems are the basis of gene therapy applications. Non-integrating lentiviral (NIL) vectors are among the most promising candidates for gene transfer tools, because they exhibit high transfer efficiency in both dividing and non-dividing cells and do not present a risk of insertional mutagenesis. However, non-integrating lentiviral vectors cannot introduce stable exogenous gene expression to dividing cells, thereby limiting their application. Here, we report the design of a non-integrating lentiviral vector that contains the minimal scaffold/matrix attachment region (S/MAR) sequence (SNIL), and this SNIL vector is able to retain episomal transgene expression in dividing cells. Using SNIL vectors, we detected the expression of the eGFP gene for 61 days in SNIL-transduced stable CHO cells, either with selection or not. In the NIL group without the S/MAR sequence, however, the transduced cells died under selection for the transient expression of NIL vectors. Furthermore, Southern blot assays demonstrated that the SNIL vectors were retained extrachromosomally in the CHO cells. In conclusion, the minimal S/MAR sequence retained the non-integrating lentiviral vectors in dividing cells, which indicates that SNIL vectors have the potential for use as a gene transfer tool.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abordo-Adesida, E., Follenzi, A., Barcia, C., Sciascia, S., Castro, M.G., Naldini, L., and Lowenstein, P.R. (2005). Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses. Hum Gene Ther 16, 741–751.
Apolonia, L., Waddington, S.N., Fernandes, C., Ward, N.J., Bouma, G., Blundell, M.P., Thrasher, A.J., Collins, M.K., and Philpott, N.J. (2007). Stable gene transfer to muscle using non-integrating lentiviral vectors. Mol Ther 15, 1947–1954.
Banasik, M.B., and McCray, P.B., Jr. (2010). Integrase-defective lentiviral vectors: progress and applications. Gene Ther 17, 150–157.
Bode, J., Kohwi, Y., Dickinson, L., Joh, T., Klehr, D., Mielke, C., and Kohwi-Shigematsu, T. (1992). Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science 255, 195–197.
Broll, S., Oumard, A., Hahn, K., Schambach, A., and Bode, J. (2010). Minicircle performance depending on S/MAR-nuclear matrix interactions. J Mol Biol 395, 950–965.
Brown, P.O., Bowerman, B., Varmus, H.E., and Bishop, J.M. (1989). Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral INprotein. Proc Natl Acad Sci USA 86, 2525–2529.
Burns, J.C., Friedmann, T., Driever, W., Burrascano, M., and Yee, J.K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 90, 8033–8037.
Butler, S.L., Johnson, E.P., and Bushman, F.D. (2002). Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J Virol 76, 3739–3747.
Cara, A., and Reitz, M.S., Jr. (1997). New insight on the role of extrachromosomal retroviral DNA. Leukemia 11, 1395–1399.
Cronin, J., Zhang, X.Y., and Reiser, J. (2005). Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5, 387–398.
Farnet, C.M., and Haseltine, W.A. (1991). Circularization of human immunodeficiency virus type 1 DNA in vitro. J Virol 65, 6942–6952.
Fried, M. (1965). Cell-transforming ability of a temperature-sensitive mutant of polyoma virus. Proc Natl Acad Sci USA 53, 486–491.
Hagedorn, C., Wong, S.P., Harbottle, R., and Lipps, H.J. (2011). Scaffold/matrix attached region-based nonviral episomal vectors. Hum Gene Ther 22, 915–923.
Jackson, D.A., Juranek, S., and Lipps, H.J. (2006). Designing nonviral vectors for efficient gene transfer and long-term gene expression. Mol Ther 14, 613–626.
Jenke, A.C., Scinteie, M.F., Stehle, I.M., and Lipps, H.J. (2004a). Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation. Mol Biol Rep 31, 85–90.
Jenke, A.C., Stehle, I.M., Herrmann, F., Eisenberger, T., Baiker, A., Bode, J., Fackelmayer, F.O., and Lipps, H.J. (2004b). Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome. Proc Natl Acad Sci USA 101, 11322–11327.
Jenke, B.H., Fetzer, C.P., Stehle, I.M., Jonsson, F., Fackelmayer, F.O., Conradt, H., Bode, J., and Lipps, H.J. (2002). An episomally replicating vector binds to the nuclear matrix protein SAF-A in vivo. EMBO Rep 3, 349–354.
Kafri, T., Blomer, U., Peterson, D.A., Gage, F.H., and Verma, I.M. (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17, 314–317.
Kohn, D.B., Sadelain, M., and Glorioso, J.C. (2003). Occurrence of leukaemia following gene therapy of X-linked SCID. Nat Rev Cancer 3, 477–488.
Kootstra, N.A., and Verma, I.M. (2003). Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol 43, 413–439.
Leavitt, A.D., Robles, G., Alesandro, N., and Varmus, H.E. (1996). Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J Virol 70, 721–728.
Manzini, S., Vargiolu, A., Stehle, I.M., Bacci, M.L., Cerrito, M.G., Giovannoni, R., Zannoni, A., Bianco, M.R., Forni, M., Donini, P., Papa, M., Lipps, H.J., and Lavitrano, M. (2006). Genetically modified pigs produced with a nonviral episomal vector. Proc Natl Acad Sci USA 103, 17672–17677.
Mirkovitch, J., Mirault, M.E., and Laemmli, U.K. (1984). Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold. Cell 39, 223–232.
Moens, U., Seternes, O.M., Johansen, B., and Rekvig, O.P. (1997). Mechanisms of transcriptional regulation of cellular genes by SV40 large T- and small T-antigens. Virus Genes 15, 135–154.
Naldini, L. (1998). Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biotechnol 9, 457–463.
Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M., and Trono, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263–267.
Nightingale, S.J., Hollis, R.P., Pepper, K.A., Petersen, D., Yu, X.J., Yang, C., Bahner, I., and Kohn, D.B. (2006). Transient gene expression by nonintegrating lentiviral vectors. Mol Ther 13, 1121–1132.
Pang, S., Koyanagi, Y., Miles, S., Wiley, C., Vinters, H.V., and Chen, I.S. (1990). High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 343, 85–89.
Panganiban, A.T., and Temin, H.M. (1983). The terminal nucleotides of retrovirus DNA are required for integration but not virus production. Nature 306, 155–160.
Papapetrou, E.P., Ziros, P.G., Micheva, I.D., Zoumbos, N.C., and Athanassiadou, A. (2006). Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element. Gene Ther 13, 40–51.
Papapetrou, E.P., Zoumbos, N.C., and Athanassiadou, A. (2005). Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects. Gene Ther 12 Suppl 1, S118–S130.
Pauza, C.D., Galindo, J.E., and Richman, D.D. (1990). Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells. J Exp Med 172, 1035–1042.
Pauza, C.D., Trivedi, P., McKechnie, T.S., Richman, D.D., and Graziano, F.M. (1994). 2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo. Virology 205, 470–478.
Piechaczek, C., Fetzer, C., Baiker, A., Bode, J., and Lipps, H.J. (1999). A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res 27, 426–428.
Pierson, T.C., Kieffer, T.L., Ruff, C.T., Buck, C., Gange, S.J., and Siliciano, R.F. (2002). Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J Virol 76, 4138–4144.
Robinson, H.L., and Zinkus, D.M. (1990). Accumulation of human immunodeficiency virus type 1 DNA in T cells: results of multiple infection events. J Virol 64, 4836–4841.
Saenz, D.T., Loewen, N., Peretz, M., Whitwam, T., Barraza, R., Howell, K.G., Holmes, J.M., Good, M., and Poeschla, E.M. (2004). Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants. J Virol 78, 2906–2920.
Schaarschmidt, D., Baltin, J., Stehle, I.M., Lipps, H.J., and Knippers, R. (2004). An episomal mammalian replicon: sequence-independent binding of the origin recognition complex. EMBO J 23, 191–201.
Slinskey, A., Barnes, D., and Pipas, J.M. (1999). Simian virus 40 large T antigen J domain and Rb-binding motif are sufficient to block apoptosis induced by growth factor withdrawal in a neural stem cell line. J Virol 73, 6791–6799.
Stevenson, M., Haggerty, S., Lamonica, C.A., Meier, C.M., Welch, S.K., and Wasiak, A.J. (1990). Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J Virol 64, 2421–2425.
Vargas, J., Jr., Gusella, G.L., Najfeld, V., Klotman, M.E., and Cara, A. (2004). Novel integrase-defective lentiviral episomal vectors for gene transfer. Hum Gene Ther 15, 361–372.
Vargas, J., Jr., Klotman, M.E., and Cara, A. (2008). Conditionally replicating lentiviral-hybrid episomal vectors for suicide gene therapy. Antiviral Res 80, 288–294.
Verghese, S.C., Goloviznina, N.A., Skinner, A.M., Lipps, H.J., and Kurre, P. (2014). S/MAR sequence confers long-term mitotic stability on non-integrating lentiviral vector episomes without selection. Nucleic Acids Res 42, e53.
Verma, I.M., and Weitzman, M.D. (2005). Gene therapy: twenty-first century medicine. Annu Rev Biochem 74, 711–738.
Wang, J., and Sugden, B. (2005). Origins of bidirectional replication of Epstein-Barr virus: models for understanding mammalian origins of DNA synthesis. J Cell Biochem 94, 247–256.
Wu, Y. (2004). HIV-1 gene expression: lessons from provirus and non-integrated DNA. Retrovirology 1, 13.
Yáñez-Muñoz, R.J., Balaggan, K.S., MacNeil, A., Howe, S.J., Schmidt, M., Smith, A.J., Buch, P., MacLaren, R.E., Anderson, P.N., Barker, S.E., Duran, Y., Bartholomae, C., von Kalle, C., Heckenlively, J.R., Kinnon, C., Ali, R.R., and Thrasher, A.J. (2006). Effective gene therapy with non-integrating lentiviral vectors. Nat Med 12, 348–353.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at link.springer.com
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Electronic supplementary material
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Xu, Z., Chen, F., Zhang, L. et al. Non-integrating lentiviral vectors based on the minimal S/MAR sequence retain transgene expression in dividing cells. Sci. China Life Sci. 59, 1024–1033 (2016). https://doi.org/10.1007/s11427-016-0067-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-016-0067-0